Literature DB >> 206631

Human foamy virus: further characterization, seroepidemiology, and relationship to chimpanzee foamy viruses.

P Brown, G Nemo, D C Gajdusek.   

Abstract

A foamy virus present in human nasopharyngeal carcinoma tissue was studied for a number of biological properties, including range of cellular susceptibility, growth curve, evolution of cytopathic effect in relation to cellular fusion and intracellular viral distribution, reverse transcriptase activity, and buoyant density. The virus was also studied immunologically and found to be closely related to the chimpanzee foamy viruses, particularly simian foamy virus type 6, with which it shares common antigens in complement-fixing, fluorescent, and neutralizing antibody tests. In view of this close immunological relationship and the failure to find antibody to the human isolate in sera from more than 250 humans, including 50 patients with nasopharyngeal carcinoma and Burkitt's lymphoma, it is suggested that the isolate is not a human representative of the foamy virus group but rather a variant strain of chimpanzee foamy virus.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 206631     DOI: 10.1093/infdis/137.4.421

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  15 in total

1.  Sensitization of rhabdo-, lenti-, and spumaviruses to human serum by galactosyl(alpha1-3)galactosylation.

Authors:  Y Takeuchi; S H Liong; P D Bieniasz; U Jäger; C D Porter; T Friedman; M O McClure; R A Weiss
Journal:  J Virol       Date:  1997-08       Impact factor: 5.103

2.  Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors.

Authors:  Grant Trobridge; David W Russell
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

3.  Human foamy virus bel1 sequence in patients with autoimmune rheumatic diseases.

Authors:  Kuang-Hui Sun; Hsiao-Yi Lin; Lee-Wen Chen; Hsiao-Yun Tai; Mei-Lin Lin; Chi-Kuang Feng; Jung-Sung Sung; Hsin-Fu Liu; Wu-Tse Liu
Journal:  Clin Rheumatol       Date:  2005-12-20       Impact factor: 2.980

4.  Studies on in vitro interferon induction capacity and interferon sensitivity of simian foamy viruses.

Authors:  A Rhodes-Feuillette; F Saal; J Lasneret; M Santillana-Hayat; J Peries
Journal:  Arch Virol       Date:  1987       Impact factor: 2.574

5.  Structure and function of the long terminal repeat of the chimpanzee foamy virus isolates (SFV-6).

Authors:  J De Celis; J Tobaly-Tapiero; A Hampe; R Emanoil-Ravier
Journal:  Arch Virol       Date:  1994       Impact factor: 2.574

6.  Simian foamy virus isolated from an accidentally infected human individual.

Authors:  M Schweizer; V Falcone; J Gänge; R Turek; D Neumann-Haefelin
Journal:  J Virol       Date:  1997-06       Impact factor: 5.103

7.  Vesicular changes in the myopathies of AIDS. Ultrastructural observations and their relationship to zidovudine treatment.

Authors:  P K Panegyres; J M Papadimitriou; P N Hollingsworth; J A Armstrong; B A Kakulas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1990-08       Impact factor: 10.154

8.  Human spumaretrovirus antibody reactivity in multiple sclerosis.

Authors:  J Lycke; B Svennerholm; A Svenningsson; W Muranyi; R M Flügel; O Andersen
Journal:  J Neurol       Date:  1994-02       Impact factor: 4.849

9.  Foamy virus vectors.

Authors:  D W Russell; A D Miller
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

10.  Persistent asymptomatic infection of the laboratory mouse by simian foamy virus type 6: a new model of retrovirus latency.

Authors:  P Brown; M C Moreau-Dubois; D C Gajdusek
Journal:  Arch Virol       Date:  1982       Impact factor: 2.574

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.